Trial Profile
Observational Study Investigating Clinical Efficacy of Fingolimod and Predictors of Relapses In An Italian Cohort of Relapsing-Remitting Multiple Sclerosis Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2016
Price :
$35
*
At a glance
- Drugs Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 18 Sep 2016 New trial record